ACE inhibitors increased the risk of acute pancreatitis (OR 1.33; 95% CI 1.12-1.58; I2 = 93%), whereas ARBs did not (OR 0.82; 95% CI 0.80-0.83; I2 = 0%). The gene discussed is ACE; the disease is acute pancreatitis.